With interest, we read the review “Role of paced breathing for treatment of hypertension” [1]. Several types of interventions were described; the main focus of the paper was on a commercially available paced breathing device called the RESPeRATE. We have concerns with the current review, which is remarkably comparable to a previous, criticized, non-systematic review by the same authors [2,…
Gliclazide has been associated with a low risk of hypoglycemic episodes and beneficial long-term cardiovascular safety in observational cohorts. The aim of this study was to assess in a systematic review and meta-analysis of randomized controlled trials the safety and efficacy of gliclazide compared to other oral glucose-lowering agents (PROSPERO2013:CRD42013004156)